Eloxx Pharmaceuticals (ELOX) SEC Filings & 10K Form $0.0001 +0.00 (+∞) As of 02/21/2025 09:30 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends Recent Eloxx Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/21/20259:00 AMEloxx Pharmaceuticals, Inc. (Filer)Eloxx Pharmaceuticals (Filer)Form SEC STAFF ACTION01/28/20254:35 PMAndroski Lindsay (Reporting)Eloxx Pharmaceuticals, Inc. (Issuer)Eloxx Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/28/20254:36 PMEloxx Pharmaceuticals, Inc. (Issuer)Eloxx Pharmaceuticals (Issuer)Rubin Steven D (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/28/20254:37 PMAggarwal Sumit (Reporting)Eloxx Pharmaceuticals, Inc. (Issuer)Eloxx Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/28/20254:34 PMEloxx Pharmaceuticals, Inc. (Issuer)Eloxx Pharmaceuticals (Issuer)Walts Alan Edmund (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/20/20247:13 PMAdvent Life Sciences LLP (Filed by)Eloxx Pharmaceuticals, Inc. (Subject)Eloxx Pharmaceuticals (Subject)Form SC 13D/A07/16/20244:23 PMEloxx Pharmaceuticals, Inc. (Filer)Eloxx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/29/20243:11 PMEloxx Pharmaceuticals, Inc. (Filer)Eloxx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/21/20241:20 PMEloxx Pharmaceuticals, Inc. (Subject)Eloxx Pharmaceuticals (Subject)Nasdaq Stock Market LLC (Filed by)Form 25-NSE03/14/20243:30 PMEloxx Pharmaceuticals, Inc. (Filer)Eloxx Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ATNFW 10Q Form LBPSW 10Q Form AEHAW 10Q Form AIMDW 10Q Form ALVOW 10Q Form ACABW 10Q Form BFRIW 10Q Form BTMDW 10Q Form BCTXW 10Q Form CELUW 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ELOX) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eloxx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eloxx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
